南都讯 记者颜鹏1月8日，深圳市精锋医疗科技股份有限公司（股票简称：精锋医疗-B，股票代码： 02675.HK）正式在香港联交所主板上市，成为新年深圳首家完成IPO的企业，发行价每股43.24港元， 公开发售获1091.94倍认购，该股开盘报59港元，较43.24港元的发行价大幅高开36.45%，市值破200 亿。 精锋医疗此次成功登陆国际资本市场，标志着企业在完成核心技术突破与商业化验证后，迈入以全球 化、规模化发展为特征的全新阶段。 精锋医疗坚持全栈自研技术路线，已形成覆盖多孔、单孔及自然腔道手术机器人的完整产品布局。公司 是中国首家、全球第二家同时推进多孔与单孔腔镜手术机器人商业化应用的企业，在多个关键技术领域 实现自主可控。公司2024年被评为瞪羚企业及胡润全球独角兽，荣获"2023年度国家科技进步二等奖"， 全球共有734项获授专利及专利申请，用硬核实力奠定行业领先地位。 随着多条产品线相继进入商业化放量阶段，精锋医疗的经营表现快速提升。根据招股书披露，公司2025 年上半年营收达1.49亿元，较2024年同期增长近4倍；同期毛利率约为62.8%，毛利规模接近1亿元，显 示出较高的商业化质量与可持续 ...

Core Insights - Agile Medical Technology (Suzhou) Co., Ltd. has recently completed a multi-hundred million RMB Series B financing round, led by Mingxi Capital, with participation from Yuanhe Holdings, Licheng Investment, and Nantong Investment Management, along with continued investment from existing shareholders Qianji Capital and Yuanhe Origin [1][2] Group 1: Financing and Investment - The funds from this financing round will be primarily used for three key areas: deepening global commercialization efforts, accelerating the research and development iteration of surgical robot product lines, and further upgrading cutting-edge technology platforms [1] Group 2: Company Background and Product Development - Founded in 2020, Agile focuses on the surgical robot industry and has completed multiple rounds of financing prior to this [2] - The core product, AGIBOT® laparoscopic surgical robot, is expected to receive approval from the National Medical Products Administration (NMPA) by March 2025 and has already been applied in over a hundred clinical cases at leading institutions such as Nanjing University Medical School Affiliated Gulou Hospital and Zhengzhou University First Affiliated Hospital [2] - Agile has established a comprehensive capability loop from research and development to market, with a production base and user training center in Suzhou, capable of producing 100 systems and 20,000 surgical instruments annually, supporting professional user training for hundreds of individuals each year [2] - The company continues to strengthen its capabilities in technology research, pipeline development, industrial operations, and commercial expansion, forming a complete system covering "R&D - certification - mass production - commercialization" [2]

Core Insights - Agile Medical Technology (Suzhou) Co., Ltd. has completed a multi-hundred million RMB Series B financing round, led by Mingxi Capital, with participation from Yuanhe Holdings, Licheng Investment, and Nantong Investment Management, along with continued investment from existing shareholders [1][2] - The funds will be primarily used for three key areas: deepening global commercialization, accelerating the R&D iteration of surgical robot product lines, and further upgrading cutting-edge technology platforms [1] Company Developments - The core product, AGIBOT® laparoscopic surgical robot, is expected to receive approval from the National Medical Products Administration (NMPA) by March 2025, and has already completed over 100 clinical applications in top-tier hospitals [1] - Agile Medical has established a comprehensive capability loop from R&D to market, with a production base in Suzhou capable of manufacturing 100 systems and 20,000 surgical instruments annually, along with professional user training for hundreds of individuals each year [1] Innovation and Market Position - As an innovator in China's surgical robot industry, Agile Medical focuses on user needs and continues to build a technological foundation based on "AGI+BOT" through independent innovation [2] - The recent financing round reaffirms the capital market's confidence in the company's development path of "innovative technology + inclusive healthcare" [2]

Core Viewpoint - The MedRobot Awards aims to recognize key players in the Chinese smart medical industry, particularly in surgical robotics, by extending the application deadline to August 8, 2025, to allow participants to better showcase their innovations and contributions [1][2]. Group 1: Award Purpose and Structure - The MedRobot Awards is designed to upgrade the evaluation perspective and industry understanding from focusing solely on "machines" to a more comprehensive view that includes pre-operative, intra-operative, and post-operative data integration and optimization [3]. - The awards reflect a shift from "device" to "ecosystem," emphasizing the importance of core components, algorithm support, manufacturing processes, and collaborative medical scenarios [2]. - The awards also transition from "single-point breakthroughs" to recognizing contributions across the entire industry chain, including business models, supply chain collaboration, hospital partnerships, and international expansion [3]. Group 2: Award Categories - Surgical Robot Systems: Targeting companies with independent brands and system development capabilities, focusing on surgical innovation, intelligence, domestic production capacity, and international performance [4]. - Surgical Robot of the Year: This award is selected from nominated companies and cannot be self-nominated [5]. - Industry Leadership Award: Recognizes surgical robot companies that have been approved for market deployment and have made significant contributions to market education and technology dissemination [6]. - Technical Innovation Award: Acknowledges breakthroughs in system architecture, key algorithms, and human-machine interaction that enhance surgical precision and clinical value [7]. - Clinical Application Excellence Award: Focuses on innovative clinical applications of surgical robots in various medical fields, encouraging multi-disciplinary submissions [8]. - Market Impact Award: Recognizes companies with broad market coverage and high user satisfaction, contributing significantly to the commercialization of the industry [10]. - Global Expansion & Collaboration Award: Acknowledges companies successfully exporting products and collaborating with international institutions [11]. Group 3: Supply Chain and Service Awards - Surgical Robot Outstanding Supply Chain Award: Recognizes key enterprises and platforms that support surgical robots through components, algorithms, and clinical validation services [12][13]. - Surgical Robot Outstanding Service Partner Award: Acknowledges service partners that provide essential support to surgical robot manufacturers [13]. Group 4: Intelligent Surgery Awards - Surgical Intelligence System Innovation Award: Targets companies providing comprehensive digital solutions for surgical processes, including pre-operative planning and post-operative follow-up [15]. - Smart Surgery Collaboration Award: Recognizes hospitals or teams that actively promote the development of intelligent surgical systems [20]. Group 5: Medical Service Robotics - Rehabilitation Robot of the Year: Focuses on companies with significant contributions in rehabilitation robotics [21]. - Nursing & Assistance Robot of the Year: Recognizes companies providing robots for nursing and assistance in clinical settings [21]. Group 6: Application Process and Timeline - The application phase is open until August 8, 2025, with subsequent evaluation and award notification phases leading to the award ceremony on September 5, 2025 [23][27].